Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
9.33
Dollar change
+0.27
Percentage change
2.92
%
IndexRUT P/E- EPS (ttm)-6.51 Insider Own2.80% Shs Outstand156.35M Perf Week-37.92%
Market Cap1.46B Forward P/E11.52 EPS next Y0.81 Insider Trans-5.56% Shs Float152.14M Perf Month-36.10%
Income-1002.24M PEG- EPS next Q0.23 Inst Own107.29% Short Float10.25% Perf Quarter-5.76%
Sales442.74M P/S3.30 EPS this Y110.85% Inst Trans-3.32% Short Ratio4.25 Perf Half Y6.02%
Book/sh-2.21 P/B- EPS next Y15.71% ROA-127.54% Short Interest15.60M Perf Year-17.29%
Cash/sh0.59 P/C15.85 EPS next 5Y- ROE-654.88% 52W Range8.07 - 15.70 Perf YTD-18.44%
Dividend Est.- P/FCF7.97 EPS past 5Y-28.37% ROI-601.74% 52W High-40.57% Beta0.57
Dividend TTM- Quick Ratio0.84 Sales past 5Y6.93% Gross Margin99.64% 52W Low15.54% ATR (14)0.83
Dividend Ex-Date- Current Ratio0.84 EPS Y/Y TTM-668.17% Oper. Margin39.17% RSI (14)22.31 Volatility8.13% 4.42%
Employees267 Debt/Eq- Sales Y/Y TTM7.83% Profit Margin-226.37% Recom1.17 Target Price18.67
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-102.65% Payout0.00% Rel Volume2.07 Prev Close9.06
Sales Surprise0.07% EPS Surprise-105.00% Sales Q/Q9.66% EarningsFeb 15 BMO Avg Volume3.67M Price9.33
SMA20-35.35% SMA50-29.62% SMA200-13.64% Trades Volume7,606,664 Change2.92%
Date Action Analyst Rating Change Price Target Change
Jan-17-24Initiated Craig Hallum Buy $21
Dec-14-23Initiated Wells Fargo Overweight $20
Nov-09-23Initiated Jefferies Buy $21
Sep-28-23Initiated JMP Securities Mkt Outperform $22
Sep-02-22Initiated CapitalOne Overweight $15
Apr-22-22Initiated Piper Sandler Overweight $16
Sep-30-20Downgrade Wells Fargo Overweight → Equal Weight $14 → $9
Jun-17-20Initiated Northland Capital Outperform $14
Jul-10-19Resumed Credit Suisse Neutral
Mar-27-19Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-29-24 04:19PM
08:37AM
06:26AM
06:08AM
06:00AM
07:30AM Loading…
Feb-23-24 07:30AM
Feb-16-24 10:15AM
09:36AM
Feb-15-24 10:45PM
08:15AM
07:26AM
07:00AM
Feb-05-24 08:50AM
Feb-01-24 04:01PM
Jan-23-24 09:55AM
07:00PM Loading…
Jan-08-24 07:00PM
06:00AM
Jan-03-24 04:01PM
Dec-12-23 04:01PM
Nov-30-23 09:45AM
Nov-21-23 04:01PM
Nov-10-23 02:45PM
11:09AM
Nov-09-23 10:25PM
08:39AM
07:46AM
07:22AM
07:00AM
Oct-26-23 04:01PM
Oct-23-23 07:30AM
12:02PM Loading…
Oct-17-23 12:02PM
Oct-16-23 06:00AM
Oct-05-23 07:30AM
Oct-03-23 11:43AM
Oct-01-23 07:15AM
Sep-26-23 11:48AM
Sep-20-23 07:36AM
Sep-19-23 12:08PM
11:39AM
Sep-12-23 08:32AM
Sep-07-23 11:30AM
Aug-12-23 08:50AM
Aug-09-23 09:24AM
Aug-08-23 11:12PM
11:05AM
09:56AM
07:00AM
Jul-28-23 02:56PM
Jul-25-23 04:01PM
Jun-29-23 08:30AM
Jun-21-23 08:00PM
Jun-16-23 07:00AM
Jun-13-23 09:18AM
Jun-12-23 04:05PM
09:54AM
May-25-23 10:32AM
May-23-23 12:07PM
May-22-23 05:43PM
04:08PM
01:11PM
12:02PM
08:40AM
07:24AM
07:22AM
06:57AM
May-09-23 04:01PM
May-08-23 07:30AM
May-05-23 09:31AM
May-04-23 08:55AM
07:00AM
Apr-26-23 08:00PM
Apr-24-23 07:30AM
Apr-20-23 04:01PM
Mar-22-23 02:53PM
Mar-14-23 02:56AM
Mar-02-23 07:09AM
Feb-27-23 04:01PM
Feb-20-23 07:40AM
Feb-17-23 11:11AM
Feb-16-23 08:35AM
07:00AM
Feb-15-23 11:09AM
Feb-14-23 10:00AM
07:20AM
Feb-13-23 07:30AM
Feb-10-23 07:40AM
Feb-09-23 10:01AM
Feb-04-23 09:40AM
Feb-02-23 04:01PM
Jan-23-23 11:07AM
Jan-16-23 05:36AM
Jan-09-23 06:00AM
Jan-04-23 04:01PM
Dec-09-22 11:30AM
Nov-22-22 04:01PM
Nov-09-22 07:47AM
Nov-04-22 12:13PM
Nov-03-22 08:35AM
07:01AM
Oct-20-22 04:01PM
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCCOURT Thomas AChief Executive OfficerFeb 12Sale15.24177,1642,699,979832,774Feb 14 08:35 PM
John MinardoChief Legal OfficerFeb 12Sale15.2447,380722,071224,796Feb 14 09:01 PM
Shetzline MichaelCMO,SVP,Head-Res&DrugFeb 12Sale15.2438,618588,538340,484Feb 14 08:53 PM
Davis AndrewSVP, Chief Business OfficerFeb 12Sale15.249,846150,053208,324Feb 14 08:42 PM
Silver RonaldPrincipal Accounting OfficerFeb 12Sale15.247,908120,518134,264Feb 14 08:50 PM
Kessler Marla LDirectorDec 14Sale11.199,926111,07296,572Dec 18 04:09 PM
Davis AndrewSVP, Chief Business OfficerNov 20Sale9.693,28731,851217,374Nov 22 04:05 PM
Emany Sravan KumarSVP, Chief Financial OfficerSep 15Buy8.3236,072300,119188,730Sep 18 05:07 PM
John MinardoChief Legal OfficerAug 14Sale10.047,04570,732192,195Aug 16 04:20 PM
Silver RonaldPrincipal Accounting OfficerAug 14Sale10.041,97619,839134,172Aug 16 04:21 PM
MCCOURT Thomas AChief Executive OfficerMay 30Sale10.7026,632284,962758,284Jun 01 05:45 PM
MCCOURT Thomas AChief Executive OfficerMay 22Sale10.1236,000364,320784,916May 24 04:05 PM
Shetzline MichaelCMO,SVP,Head-Res&DrugMay 22Sale10.1210,324104,479321,131May 24 04:05 PM
Davis AndrewSVP, Chief Business OfficerMay 22Sale10.126,30563,807219,327May 24 04:05 PM
MCCOURT Thomas AChief Executive OfficerMay 08Sale10.6221,148224,592820,916May 10 04:05 PM
MCCOURT Thomas AChief Executive OfficerMar 27Sale10.6746,129492,196842,064Mar 29 04:05 PM